CN1077437C - Chinese patent medicine for treating prostatic diseases - Google Patents
Chinese patent medicine for treating prostatic diseases Download PDFInfo
- Publication number
- CN1077437C CN1077437C CN99114782A CN99114782A CN1077437C CN 1077437 C CN1077437 C CN 1077437C CN 99114782 A CN99114782 A CN 99114782A CN 99114782 A CN99114782 A CN 99114782A CN 1077437 C CN1077437 C CN 1077437C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- chinese patent
- root
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 208000025844 Prostatic disease Diseases 0.000 title abstract 2
- 241000195474 Sargassum Species 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 5
- 206010060862 Prostate cancer Diseases 0.000 abstract description 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000725152 Caladium Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 206010051482 Prostatomegaly Diseases 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 230000003068 static effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 210000002307 prostate Anatomy 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000011265 semifinished product Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000459479 Capsula Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960003418 phenoxybenzamine Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a Chinese patent medicine for treating prostatic diseases, which fully utilizes the function of smoothing liver of bupleurum root, the function of promoting static blood circulation of liver channels of Chinese angelica, red peony root and danshen root, the function of guiding medicine of achyranthes root, the functions of softening and resolving hard mass and eliminating lump of oyster, bryozoatum, figwort root, caladium, common selfheal fruit-spike, seaweed and laminariam, and the functions of clearing away heat and toxic material, treating boils, eliminating tumors, etc. of oldenlandia diffusa and barbated skullcup herb. The Chinese patent medicine has significant curative effects on prostatomegaly and early prostatic cancer. After tested in clinic, the medicine can fundamentally solve the problem that the existing medicine is difficult to provide fundamental solution to the symptoms of the diseases, and the cure rate reaches 90%; the components of the medicine are easily obtained and are low in cost.
Description
The present invention relates to a kind of Chinese patent medicine, particularly a kind of Chinese patent medicine and preparation method for the treatment of prostate hyperplasia, early prostate cancer.
Prostatosis is that disease is seen in a kind of feel that middle-aging male is easily suffered from, frequently-occurring disease, and this disease is not only brought great misery to extensive patients, and cure rate is lower, belongs to the disease of refractory.The drug main of existing treatment prostatosis will adopt the antibiotics of Western medicine, as estrogen, QIANLIEKANG, NANKANG, Phenoxybenzamine etc., this class antibiolics is difficult for the infiltration capsula prostatica, make the interior medicine effective concentration of body of gland low, and poison pair effect is big, takes for a long time easily to cause other complication.The Chinese patent medicine or the Chinese herbal medicine of treatment prostatosis, though the effect of paying is less, therapeutic effect is all not remarkable, and cure rate is low, therefore, can not satisfy numerous patients' requirement.
The object of the present invention is to provide a kind ofly treat significantly, cure rate is high, do not have the treatment prostate hyperplasia of the effect of paying, the Chinese patent medicine of early prostate cancer.
The present invention says according to the three warmers of theory of Chinese medical science, that is:
The part of the body cavity above the diaphragm housing the heart and lungs: lung governing coordinative activities of viscera, be source on the water, regulating fluid apssage, following defeated bladder, pneumonopathy then lung qi can not be failed cloth, influences that water channel is logical to be transferred, with urine retention or urine to have freely;
Middle burnt: the spleen and stomach function disorder, damp-heat flowing down to the urinary bladder, and it is not normal to gasify, and urine can not normally be drained, and based on urine retention and stagnant wet, deficiency-weakness of spleen-QI can not be received and take the photograph, and bladder loses in constraint, and water can not hold, based on enuresis incontinence;
The part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels: old kidney qi degradation, following first deficiency and coldness, gasification is not enough, with frequency of micturition, stagnate wet not well be main;
Divide the pathogenic factor fold prostatosis, and adopt soft perpendicular, removing food stagnancy, the bullate method of loosing to make up a prescription, fundamentally to treat prostatosis at this disease.
The present invention is that following row raw materials by weight percent is made:
Radix Bupleuri 3-10%, Concha Ostreae 8-14%,
Qin Danggui 4-10%, Bulbus Fritillariae Uninbracteatae 4-7%,
Radix Paeoniae Rubra 4-8%, Herba Scutellariae Barbatae 2-5%,
Spica Prunellae 7-13%, Radix Achyranthis Bidentatae 4-8%,
Pumex 4-8%, Radix Salviae Miltiorrhizae sends out 7-12%,
Thallus Laminariae (Thallus Eckloniae) 5-9%, Radix Scrophulariae 8-13%,
Sargassum 4-8%, Herba Hedyotidis Diffusae 3-8%.
Wherein, Radix Paeoniae Rubra can replace with Flos Carthami; Radix Scrophulariae can replace with the Radix Rehmanniae.
The present invention is that following row raw materials by weight percent is made;
Radix Bupleuri 5-8%, Concha Ostreae 9-13%,
Qin Danggui 5-8%, Bulbus Fritillariae Uninbracteatae 4-6%,
Radix Paeoniae Rubra 4-6%, Herba Scutellariae Barbatae 2-4%,
Spica Prunellae 8-12%, Radix Achyranthis Bidentatae 4-6%,
Pumex 4-7%, Radix Salviae Miltiorrhizae 9-12%,
Thallus Laminariae (Thallus Eckloniae) 4-8%, Radix Scrophulariae 9-11%,
Sargassum 4-8%, Herba Hedyotidis Diffusae 4-6%.
Radix Bupleuri bitter in the mouth wherein, suffering are slightly cold, energy reducing fever by reconciliation, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.Cure mainly proctoptosis due to dry pharynx, dizzy, distending pain over the hypochondrium, headache, the collapse of QI etc.;
Sargassum, Thallus Laminariae (Thallus Eckloniae) salty in the mouth are trembled with fear, the diuretic that can disappear, and softening the hard mass cures mainly beriberi edema, edema;
Radix Achyranthis Bidentatae bitter in the mouth, acid, flat, the energy blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards cures mainly weakness of the lower extremities, hematuria, dysuria, aphtha of the mouth and tongue, it is dizzy to have a headache;
The Concha Ostreae salty in the mouth, be slightly cold, can suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving restrain astringent or styptic treatment for spontaneous sweatingly, cures mainly dysphoria, and palpitation and insomnia is had a dizzy spell, and hard masses softening and resolving is filtered antiperspirant, seminal emission, leukorrhagia etc.
The Spica Prunellae bitter in the mouth is hot cold, can clearing away liver-fire, and Disperse hepatic depression, blood pressure lowering cures mainly on the liver-fire and reaches conjunctival congestion and swelling pain, scrofula disease, goiter.
The Radix Salviae Miltiorrhizae bitter in the mouth is slightly cold, can blood circulation promoting and blood stasis dispelling, and the removing heat from blood pain that disappears is reposed, and cures mainly trusted subordinate's pain, and limbs swell and ache etc.
Bulbus Fritillariae Uninbracteatae bitter in the mouth, cold can preventing phlegm from forming and stopping coughing, and the heat clearing away eliminating stagnation cures mainly chronic cough of deficiency lung, the few parched throat of expectorant, the sick skin ulcer pain of scrofula, swell and ache, pain in the lung etc.
Drug component provided by the invention makes full use of the Radix Bupleuri soothing liver-QI for relieving depression, the blood stasis of Qin Danggui, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae reason Liver Channel, the Radix Achyranthis Bidentatae priming is descending, Concha Ostreae, Pumex, Radix Scrophulariae, Bulbus Fritillariae Uninbracteatae, Spica Prunellae, Sargassum, Thallus Laminariae (Thallus Eckloniae) hard masses softening and resolving, detumescence piece, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae heat-clearing and toxic substances removing, effects such as pain, the cancerous protuberance that disappears disappear, prostate hyperplasia, early prostate cancer disease had significant curative effect, by clinical verification, it can fundamentally solve the disease that present stage is difficult to effect a permanent cure with medicine, cure rate reaches 90%, and drug component is easy to get, and cost is low.
Below in conjunction with embodiment the present invention is described further.
Embodiment 1
Adopt following component formulated:
Radix Bupleuri 5%, Concha Ostreae 13%,
Qin Danggui 5%, Bulbus Fritillariae Uninbracteatae 4%,
Radix Paeoniae Rubra 6%, Herba Scutellariae Barbatae 2%,
Spica Prunellae 12%, Radix Achyranthis Bidentatae 6%,
Pumex 5%, Radix Salviae Miltiorrhizae 12%,
Thallus Laminariae (Thallus Eckloniae) 8%, Radix Scrophulariae 11%,
Sargassum 5%, Herba Hedyotidis Diffusae 6%.
The said medicine component is mixed, soak and fry in shallow oil juice, behind the filter and remove residue, be condensed into semi-finished product, again through being drying to obtain patent medicine.
Embodiment 2
Adopt following component formulated:
Radix Bupleuri 10%, Concha Ostreae 8%,
Qin Danggui 10%, Bulbus Fritillariae Uninbracteatae 6%,
Radix Paeoniae Rubra 4%, Herba Scutellariae Barbatae 5%,
Spica Prunellae 7%, Radix Achyranthis Bidentatae 8%,
Pumex 8%, Radix Salviae Miltiorrhizae 7%,
Thallus Laminariae (Thallus Eckloniae) 6%, Radix Scrophulariae 8%,
Sargassum 8%, Herba Hedyotidis Diffusae 4%.
The said medicine component is mixed, soak and fry in shallow oil juice, behind the filter and remove residue, be condensed into semi-finished product, again through being drying to obtain patent medicine.
Embodiment 3
Adopt following component formulated:
Radix Bupleuri 6%, Concha Ostreae 10%,
Qin Danggui 6%, Bulbus Fritillariae Uninbracteatae 7%,
Radix Paeoniae Rubra 5%, Herba Scutellariae Barbatae 5%,
Spica Prunellae 10%, Radix Achyranthis Bidentatae 5%,
Pumex 6%, Radix Salviae Miltiorrhizae 10%,
Thallus Laminariae (Thallus Eckloniae) 6%, Radix Scrophulariae 10%,
Sargassum 7%, Herba Hedyotidis Diffusae 8%.
The said medicine component is mixed, soak and fry in shallow oil juice, behind the filter and remove residue, be condensed into semi-finished product, again through being drying to obtain patent medicine.
Case
Lee, man, 72 years old, because of the urinary obstruction hospitalization, its prostatic size is respectively 7 * 5 * 3.4 on inspection, and catheter is urinated in the use, take existing medicine simultaneously, through 2 months no positive effects of treatment, the medicine of taking the present invention was after 5 days, the urine nature is unobstructed, and the dial-out catheter, after taking medicine continuously, the prostate size is respectively 6 * 4 * 3 on inspection again, unobstructed micturition is until recovering normal.
Claims (3)
1, a kind of Chinese patent medicine for the treatment of prostatosis is characterized in that it is that following row raw materials by weight percent is made:
Radix Bupleuri 3-10%, Concha Ostreae 8-14%,
Qin Danggui 4-10%, Bulbus Fritillariae Uninbracteatae 4-7%,
Radix Paeoniae Rubra 4-8%, Herba Scutellariae Barbatae 2-5%,
Spica Prunellae 7-13%, Radix Achyranthis Bidentatae 4-8%,
Pumex 4-8%, Radix Salviae Miltiorrhizae 7-12%,
Thallus Laminariae (Thallus Eckloniae) 5-9%, Radix Scrophulariae 8-13%,
Sargassum 4-8%, Herba Hedyotidis Diffusae 3-8%.
2, Chinese patent medicine according to claim 1 is characterized in that it is that following row raw materials by weight percent is made;
Radix Bupleuri 5-8%, Concha Ostreae 9-13%,
Qin Danggui 5-8%, Bulbus Fritillariae Uninbracteatae 4-6%,
Radix Paeoniae Rubra 4-6%, Herba Scutellariae Barbatae 2-4%,
Spica Prunellae 8-12%, Radix Achyranthis Bidentatae 4-6%,
Pumex 4-7%, Radix Salviae Miltiorrhizae 9-12%,
Thallus Laminariae (Thallus Eckloniae) 4-8%, Radix Scrophulariae 9-11%,
Sargassum 4-8%, Herba Hedyotidis Diffusae 4-6%.
3, Chinese patent medicine according to claim 1 is characterized in that Radix Paeoniae Rubra replaces with Flos Carthami; Radix Scrophulariae replaces with the Radix Rehmanniae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114782A CN1077437C (en) | 1999-04-08 | 1999-04-08 | Chinese patent medicine for treating prostatic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114782A CN1077437C (en) | 1999-04-08 | 1999-04-08 | Chinese patent medicine for treating prostatic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1270054A CN1270054A (en) | 2000-10-18 |
| CN1077437C true CN1077437C (en) | 2002-01-09 |
Family
ID=5277825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99114782A Expired - Fee Related CN1077437C (en) | 1999-04-08 | 1999-04-08 | Chinese patent medicine for treating prostatic diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1077437C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103933358B8 (en) * | 2014-04-29 | 2016-08-24 | 青岛市海慈医疗集团 | A kind of medicine treating prostate cancer |
| CN104491312A (en) * | 2014-12-22 | 2015-04-08 | 广东聚智诚科技有限公司 | Use of tradtional Chinese medicine preparation in preparing medicines for treating prostatitis and prostatauxe |
| CN107982402A (en) * | 2017-12-29 | 2018-05-04 | 黄备芳 | A kind of Chinese medicine for treating cancer |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1115698A (en) * | 1994-03-18 | 1996-01-31 | Sms舒路曼-斯玛公司 | Apparatus for working roller during rolling |
| CN1163761A (en) * | 1996-04-26 | 1997-11-05 | 李建平 | Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia |
-
1999
- 1999-04-08 CN CN99114782A patent/CN1077437C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1115698A (en) * | 1994-03-18 | 1996-01-31 | Sms舒路曼-斯玛公司 | Apparatus for working roller during rolling |
| CN1163761A (en) * | 1996-04-26 | 1997-11-05 | 李建平 | Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1270054A (en) | 2000-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN103520680B (en) | The Chinese medicine for the treatment of acute heart failure | |
| CN103055260B (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN1243561C (en) | Chinese medicine for cancer | |
| CN1077437C (en) | Chinese patent medicine for treating prostatic diseases | |
| CN104147388B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
| CN1231239C (en) | Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof | |
| CN106377720A (en) | Stomach medicine and preparation method thereof | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN104398733A (en) | Traditional Chinese medicine preparation for treating liver depression and qi stagnation type thyroid cancer | |
| CN1257745C (en) | Chinese medicinal composition for treating typhoid | |
| CN103893634B (en) | Traditional Chinese medicine for treating infantile cholestasis | |
| CN103386055B (en) | Qianlieantong capsule and preparation method thereof | |
| CN109700976B (en) | Qie and zedoary liver-protecting paste | |
| CN101991737A (en) | Stomach medicine | |
| CN1883552A (en) | A Chinese medicine for treating mastopathy and method for preparing same | |
| CN101028418A (en) | Medicine for tumor | |
| CN104083548A (en) | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof | |
| CN113509519B (en) | Traditional Chinese medicine compound for treating knee osteoarthritis and preparation method thereof | |
| CN1049596C (en) | Medicine composite for curing arthritis | |
| CN105998737A (en) | Traditional Chinese medicinal composition for treating hypogastric pain | |
| CN111481649A (en) | External traditional Chinese medicine composition for treating breast cancer and preparation method thereof | |
| CN106692588A (en) | Traditional Chinese medicine formula for treating liver cirrhosis | |
| CN105362986A (en) | Traditional Chinese medicine composition for treating rheumatism cold disease | |
| CN1907345A (en) | Chinese traditional medicine composition for treating cerebral apoplexy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |